- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
China signs deal to ensure COVID vaccines to developing countries
She gave no details on how much money China would commit to the deal, which has a fundraising goal of $2 billion and aims to provide 92 low and middle-income countries with a future vaccine.
China: China has signed up to a deal to ensure future Covid-19 vaccines are distributed to developing countries, the biggest economy yet to join the World Health Organization-led bid to control the pandemic. The COVAX pledge to get vaccines to poorer nations as soon as they are developed aims to head off fears rich countries will limit distribution of game-changing medicines made by...
China: China has signed up to a deal to ensure future Covid-19 vaccines are distributed to developing countries, the biggest economy yet to join the World Health Organization-led bid to control the pandemic. The COVAX pledge to get vaccines to poorer nations as soon as they are developed aims to head off fears rich countries will limit distribution of game-changing medicines made by their pharmaceutical companies.
Read also: Two-thirds of active ingredients for generic drugs manufactured in Asia: European Study
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751